BackgroundCheck.run
Search For

Geoffrey S Hird, 50105 Silver Cedar Ln, Chapel Hill, NC 27514

Known as:
Geoffrey Scott Hird Gregory S Hird Jeff S Hird Geoffrey S Geoffrey Geoffrey S Amy Geoff Hird Geoff S Hiro
Related to:
Paul A Hird 70

Geoffrey Hird Phones & Addresses

105 Silver Cedar Ln, Chapel Hill, NC 27514    919-2404443   

Rumson, NJ   

4619 Carlton Crossing Dr, Durham, NC 27713    919-4038057   

3 River Birch Rd, Durham, NC 27705    919-3091063   

Williamsburg, VA   

105 Silver Cedar Ln, Chapel Hill, NC 27514    919-4038057   

Social networks

Geoffrey S Hird

Linkedin

Work

Company: Eisai Dec 2010 Position: Principal scientist formulation and drug delivery technology

Education

Degree: Ph.D. School / High School: Duke University 1996 to 2001 Specialities: Chemistry

Skills

Formulation • Drug Delivery • Pharmaceutical Industry • Chemistry • Drug Discovery • Drug Development • Gmp • Biotechnology • Technology Transfer • Hplc • Product Development • Pharmaceutics • Analytical Chemistry • Chromatography • Pharmaceuticals • Uv/Vis • Organic Chemistry • Uv/Vis Spectroscopy • Injectables

Languages

English

Interests

Science and Technology

Industries

Pharmaceuticals
Get Report
Control this profile

Mentions for Geoffrey S Hird

Geoffrey Hird resumes & CV records

Resumes

Geoffrey Hird Photo 10

Executive Director Pharmaceutics And Cmc

Location:
105 Silver Cedar Ln, Chapel Hill, NC 27514
Industry:
Pharmaceuticals
Work:
Eisai since Dec 2010
Principal Scientist Formulation and Drug Delivery Technology University of North Carolina at Chapel Hill since Jan 2011
Adjunct Assistant Professor; Eshelman School of Pharmacy Eisai 2001 - 2010
Research Scientist
Education:
Duke University 1996 - 2001
Ph.D., Chemistry The College of William and Mary 1992 - 1996
BS, Chemistry RFH 1989 - 1992
High School
Skills:
Formulation, Drug Delivery, Pharmaceutical Industry, Chemistry, Drug Discovery, Drug Development, Gmp, Biotechnology, Technology Transfer, Hplc, Product Development, Pharmaceutics, Analytical Chemistry, Chromatography, Pharmaceuticals, Uv/Vis, Organic Chemistry, Uv/Vis Spectroscopy, Injectables
Interests:
Science and Technology
Languages:
English

Publications & IP owners

Us Patents

Carbohydrate Based Lipid Compositions And Supramolecular Structures Comprising Same

US Patent:
2002003, Mar 21, 2002
Filed:
Jun 8, 2001
Appl. No.:
09/877391
Inventors:
Mark Grinstaff - Durham NC, US
Geoffrey Hird - Durham NC, US
International Classification:
A61K048/00
C07H005/06
C07K016/46
C07F009/572
A61K039/395
US Classification:
514/044000, 424/178100, 424/450000, 514/023000, 530/391100, 536/018700, 548/413000, 549/006000
Abstract:
A lipid compound comprising: where Cto Care stereochemical centers; n=5, 6, 7 or 8; R, R, R, R, Rand Rare the same or different, and are selected from the group consisting of H, OH, amine, thiol, methoxy, straight or branched chain ester of 6-50 carbon atoms, straight or branched chain silane of 6-50 carbon atoms, straight or branched chain amide of 6-50 carbon atoms, straight or branched chain urea of 6-50 carbon atoms, straight or branched chain urethane of 6-50 carbon atoms, straight or branched chain carbonate of 6-50 carbon atoms, straight or branched chain sulfate of 6-50 carbon atoms, straight or branched chain thiol-urethane of 6-50 carbon atoms, straight or branched chain phosphate of 6-50 carbon atoms, straight or branched chain amine of 6-50 carbon atoms, straight or branched chain thio-urea of 6-50 carbon atoms, straight or branched chain thio-ether of 6-50 carbon atoms, straight or branched chain thio-ester of 6-50 carbon atoms, straight or branched chain ether of 6-50 carbon atoms, and any combination thereof, wherein the chain is fully saturated, full unsaturated or any combination thereof; M and X1 are O, S, or N—R, wherein Ris H, a lower alkane, a chain as recited for R, R, R, Se or any isoelectronic species of oxygen and a=0, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10; Xis phosphonate, phosphate, boronophosphate, thiophosphate, or selenophosphate and b is 0, 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10; X=methylene or a monomer selected from the group consisting of an ether, an ester, an amine, acrylic acid, amino acid, a nucleic acid, or a monosaccharide, and c=0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, or 20; X=hydroxide, N-succinyl derivative, a monomer selected from the group consisting of an amine, an ether, an ester, an amino acid, monosaccharide, and a nucleic acid, N—(R)e where Ris hydrogen or methylene chain of 1-20 carbons, or cyclic forms thereof d=0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 and e=1, 2 or 3.

Solubilized Riboflavin

US Patent:
2003016, Aug 28, 2003
Filed:
Dec 19, 2001
Appl. No.:
10/024876
Inventors:
Geoffrey Hird - Durham NC, US
Bill Lambert - Raleigh NC, US
International Classification:
A61K031/724
A61K031/525
A61K009/127
US Classification:
424/450000, 514/251000, 514/058000
Abstract:
In recognition of the need to facilitate the use of riboflavin as a pharmaceutical and additionally to increase the efficacy of water soluble forms of riboflavin (that may contain precipitated riboflavin), the present invention provides solubilized riboflavin, methods for solubilizing riboflavin and kits comprising solubilized riboflavin.

Pharmaceutical Composition Comprising 5' Monophosphate Ester Of Riboflavin And Solubilized Riboflavin

US Patent:
2003016, Aug 28, 2003
Filed:
Dec 19, 2001
Appl. No.:
10/024877
Inventors:
Adam Grobin - Chapel Hill NC, US
Geoffrey Hird - Durham NC, US
Bill Lambert - Raleigh NC, US
Katsumi Onai - Haguri-gun, JP
Stuart Pullen - Chapel Hill NC, US
International Classification:
A61K031/675
A61K031/525
US Classification:
514/081000, 514/251000
Abstract:
In recognition of the need to facilitate the use of riboflavin as a pharmaceutical and additionally to increase the efficacy and stability of water soluble forms of riboflavin (that may contain precipitated riboflavin or that are subject to photodegradation), the present invention provides solubilized riboflavin, methods for solubilizing riboflavin, kits comprising solubilized riboflavin and provides photostable compositions comprising riboflavin and derivatives thereof.

Precision Controlled Load And Release Particles For Post-Operative Pain

US Patent:
2019020, Jul 11, 2019
Filed:
May 5, 2017
Appl. No.:
16/099118
Inventors:
- Morrisville NC, US
Jacob J. Sprague - Cary NC, US
Ashley Galloway - Cary NC, US
Geoffrey Hird - Chapel Hill NC, US
Marquita Nicole Lilly - Garner NC, US
Akihisa Nonoyama - Apex NC, US
Edward Graham Randles - Durham NC, US
Benjamin Maynor - Durham NC, US
Assignee:
LIQUIDIA TECHNOLOGIES, INC. - Morrisville NC
International Classification:
A61K 31/445
A61K 47/26
A61K 47/36
A61K 47/10
A61K 31/167
A61K 31/47
A61K 31/381
A61K 9/00
A61K 9/16
Abstract:
A composition to induce analgesia includes a plurality of particles, each particle of the plurality having 40-60 wt % amino amide anesthetic or a pharmaceutically acceptable salt, hydrate, or solvate thereof and 60-40 wt % PLGA polymer including 48:52 to 52:48 molar ratio D,L lactide:glycolide and an inherent viscosity of about 0.16 to 0.24 dL/g at 0.1% w/v in chloroform at 25 C. Each particle includes a non-spherical shape less than 100 μιτι in a broadest dimension, and having a volume of about 13,500 cubic micrometers. The amino amide anesthetic is crystalline and includes 50-70% crystalline form I and 30-50% crystalline form II.

Possible Relatives

David T Hird  Daniel M Hird  Dorothy Hird  Everton H Hird  Gloria M Hird  James R Hird  Jeffrey S Hird  Geoffrey R Johnson  Geoffrey L Stamps  Geoffrey S Stanfield 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.